The absence of serious adverse events, treatment-related withdrawals, IGF-1 elevation, glucose metabolism impairment, or immunogenic responses represents a favorable safety foundation
Do not assume these supplies are included unless the item description specifically says so
What This Program Supports|Cellular energy production and metabolism
The treatment groups outperformed placebo by 5.5 (Group A) to 7.4 (Group B), providing clear evidence that the improvement was caused by the active ingredients, not the placebo effect
5 Amino-1-MQ (5-amino-1-methylquinolinium) is supplied as a high-purity lyophilised powder (HPLC/MS verified)
Scientific References (External Links) Nature Chemical Biology: Small molecule inhibitors of nicotinamide N-methyltransferase View Study Biochemical Pharmacology: Nicotinamide N-methyltransferase: A promising target for treating metabolic disorders View Study FASEB Journal: Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity in mice View Study Journal of Biological Chemistry: Inhibition of nicotinamide N-methyltransferase in vivo regulates cellular energy metabolism View Study